Scientists test 'Cancer-Fighting Virus' in patients with advanced tumors
Disease control
Completed
This early-stage trial tested the safety of a new experimental treatment called TILT-123, a genetically modified virus designed to infect and kill cancer cells. The virus was injected directly into tumors in 32 patients with advanced solid cancers that had stopped responding to s…
Phase: PHASE1 • Sponsor: TILT Biotherapeutics Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC